Literature DB >> 17236584

[Expression and clinical significance of focal adhesion kinase in oral squamous cell carcinoma].

Zhi-Xiu He1, Hua-Wei He, Dan Wang, Mei-Xian Fang.   

Abstract

OBJECTIVE: To study the correlation between expression levels of focal adhesion kinase (FAK) in oral squamous cell carcinoma (OSCC) and clinical prognosis with pathologic parameters.
METHODS: Eighty paraffin embedded tissue specimens of OSCC were studied by immunohistochemistry. The data was analyzed by SPSS statistical software.
RESULTS: FAK was highly expressed in OSCC tissues, in contrast to none or a low expression in normal oral epithelial tissue, and the heterogeneous staining was mainly located in the cell membrane and cytoplasm. FAK overexpression significantly correlated with histological differentiation and TNM stage, lymphatic metastasis. Multivariate analysis revealed that overexpression of FAK was the independent prognostic factor.
CONCLUSION: The overexpression of FAK in the peripheral area of OSCC may serve as a useful biological factor affecting prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17236584

Source DB:  PubMed          Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-173X


  3 in total

Review 1.  Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights.

Authors:  Hyunho Yoon; Joshua P Dehart; James M Murphy; Ssang-Taek Steve Lim
Journal:  J Histochem Cytochem       Date:  2014-11-07       Impact factor: 2.479

2.  SNAI1 expression and the mesenchymal phenotype: an immunohistochemical study performed on 46 cases of oral squamous cell carcinoma.

Authors:  Joerg Schwock; Grace Bradley; James C Ho; Bayardo Perez-Ordonez; David W Hedley; Jonathan C Irish; William R Geddie
Journal:  BMC Clin Pathol       Date:  2010-02-05

3.  MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK.

Authors:  Yong-Jian Wang; Zi-Feng Zhang; Shao-Hua Fan; Juan Zhuang; Qun Shan; Xin-Rui Han; Xin Wen; Meng-Qiu Li; Bin Hu; Chun-Hui Sun; Bin Qiao; Qian Tao; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  Oncotarget       Date:  2017-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.